Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

SUCROSE CRS (200 MG)

SUCROSE CRS (200 MG)

57-50-1

DISCOVER
SUFENTANIL - REFERENCE SPECTRUM (N/A)

SUFENTANIL - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
SUFENTANIL CITRATE - REFERENCE SPECTRUM (N/A)

SUFENTANIL CITRATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Simvastatin

Simvastatin

79902-63-9

DISCOVER
Salinomycin sodium salt

Salinomycin sodium salt

55721-31-8

DISCOVER
SULFACETAMIDE SODIUM CRS (50 MG)

SULFACETAMIDE SODIUM CRS (50 MG)

127-56-0

DISCOVER
Selamectin

Selamectin

220119-17-5

DISCOVER
Spectinomycin 2HCl

Spectinomycin 2HCl

21736-83-4

DISCOVER
SULFADIAZINE CRS (100 MG)

SULFADIAZINE CRS (100 MG)

68-35-9

DISCOVER
SULFADIMIDINE CRS (100 MG)

SULFADIMIDINE CRS (100 MG)

57-68-1

DISCOVER
SULFADOXINE CRS (50 MG)

SULFADOXINE CRS (50 MG)

2447-57-6

DISCOVER
Salbutamol sulfate

Salbutamol sulfate

51022-70-9

DISCOVER